Inventor
JACKY BIRGITTE P S
US17 patents
⚠️ This page may combine multiple inventors who share the name “JACKY BIRGITTE P S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZHU HONG
13 patentsUS8455213B2Jun 4, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG14 citations92
US8455247B2Jun 4, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG10 citations92
US9625447B2Apr 18, 2017
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG2 citations83
US8691566B1Apr 8, 2014
Cells useful for immuno-based botulinum toxin serotype a activity assays
ZHU HONG4 citations83
US8507271B2Aug 13, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG6 citations83
US8501469B2Aug 6, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG6 citations83
US8476068B2Jul 2, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG3 citations73
US8455248B2Jun 4, 2013
Cells useful for immuno-based Botulinum toxin serotype A activity assays
ZHU HONG4 citations73
US8663983B2Mar 4, 2014
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG0 citations62
US8663982B2Mar 4, 2014
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG0 citations62
US8603812B2Dec 10, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG0 citations62
US8603813B2Dec 10, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG0 citations62
US8476069B2Jul 2, 2013
Cells useful for immuno-based botulinum toxin serotype A activity assays
ZHU HONG1 citations62
ALLERGAN INC
3 patentsUS8361789B2Jan 29, 2013
Cells useful for immuno-based Botulinum toxin serotype A activity assays
ALLERGAN INC13 citations92
US10912823B2Feb 9, 2021
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
ALLERGAN INC0 citations56
US11149262B2Oct 19, 2021
Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation
ALLERGAN INC1 citations55